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The Tip protein of Herpesvirus saimiri strain 484C binds to and activates the Lck tyrosine protein kinase. Two sequences
in the Tip protein were previously shown to be involved in binding to Lck. A proline-rich region, residues 132–141, binds to
the SH3 domain of the Lck protein. We show here that the other Lck-binding domain, residues 104–113, binds to the
carboxyl-terminal half of Lck and that this binding does not require the Lck SH3 domain. Mutated Tip containing only one
functional Lck-binding domain can bind stably to Lck, although not as strongly as wild-type Tip. Interaction of Tip with Lck
through either Lck-binding domain increases the activity of Lck in vivo. Simultaneous binding of both domains is required for
maximal activation of Lck. The transient expression of Tip in T cells was found to stimulate both Stat3-dependent and
NF-AT-dependent transcription. Mutant forms of Tip lacking one or the other of the two Lck-binding domains retained the
ability to stimulate Stat3-dependent transcription. Tip lacking the proline-rich Lck-binding domain exhibited almost wild-type
activity in this assay. In contrast, ablation of either Lck-binding domain abolished the ability of Tip to stimulate NF-AT-
dependent transcription. Full biological activity of Tip, therefore, appears to require both Lck-binding domains. © 2000
Academic PressINTRODUCTION
New World monkeys (Mele´ndez et al., 1971) or New
ealand white rabbits (Daniel et al., 1974) infected with
erpesvirus saimiri (HVS) rapidly succumb to lymphoma
r leukemia of T-cell origin. Human peripheral blood
ymphocytes can also be infected and transformed in
itro by group C strains of this virus (Biesinger et al.,
1992; Medveczky et al., 1993). Cells that are transformed
by HVS of strain 484C are phenotypically mature periph-
eral T cells of predominantly the CD8 single-positive
lineage (Medveczky et al., 1993). HVS-transformed cells
have been shown to express and secrete interleukin-2 in
the absence of T-cell antigen receptor stimulation (Chou
et al., 1995). Work with two strains of Herpesvirus saimiri
(484C and 488C) has demonstrated that the left end of
the viral genome is required for the transforming poten-
tial, but dispensable for viral replication (Desrosiers et
al., 1985; Koomey et al., 1984; Medveczky et al., 1993).
Two open reading frames have been identified within
this region that are expressed from a single, bicistronic
mRNA (Murthy et al., 1989). One of these open reading
1 Present address: Boston University, Department of Biology, Boston,
A 02215.
2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (619) 457-4765. E-mail: sefton@salk.edu.
339frames encodes the tyrosine kinase interacting protein,
or Tip, so named because it binds tightly to the Lck
tyrosine protein kinase (Biesinger et al., 1995; Lund et al.,
1996). The other open reading frame encodes a protein
called STP (for saimiri transforming protein) (Murthy et
al., 1989). Both Tip and STP are necessary for the trans-
forming ability of strains that express both proteins
(Duboise et al., 1998a; Medveczky et al., 1993). Our in-
vestigation of the interaction of Tip with the Lck kinase
are reported here.
Lck is a member of the Src family of cytoplasmic
tyrosine protein kinases whose expression is largely
restricted to lymphoid cells (Sefton, 1991). Mice lacking
an Lck gene produce only 10% as many T cells as do
normal mice (Molina et al., 1992). Additionally, Lck is
important in signaling from the T-cell antigen receptor in
mature T cells. A derivative of the Jurkat cell line that has
lost expression of Lck, JCaM1, is unresponsive to stim-
ulation through the T-cell receptor (Straus and Weiss,
1992). Because reintroduction of Lck restores signaling,
it is clear that it is the absence of Lck that is responsible
for the signaling defect in these cells. The T-cell receptor
and the ZAP-70 tyrosine protein kinase are both likely to
be direct substrates of Lck. Finally, expression of an
activated form of Lck in T-cell lines leads to spontane-
ous, antigen-independent production of interleukin-2
(Luo and Sefton, 1992). This indicates that Lck-activated
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340 HARTLEY ET AL.pathways can lead to transcriptional activation of the
promoter for interleukin-2. In light of the important role
that Lck plays in T-cell growth and differentiation, it is
reasonable to suspect that the interaction of the Herpes-
virus saimiri Tip protein with Lck plays a role in the
induction of T-cell disease by the virus.
Lck is a 56-kDa cytoplasmic tyrosine protein kinase
that is anchored to the plasma membrane through a
fatty-acylated amino terminus (Fig. 1) (Paige et al., 1993;
urchak and Sefton, 1995). It contains an SH3 domain
hat binds to polyproline type II helices (Yu et al., 1994)
nd an SH2 domain that binds to sites of tyrosine phos-
horylation (Eck et al., 1993). These domains have the
otential to bind intramolecularly to the linker between
he SH2 domain and the catalytic domain, and to phos-
horylated tyrosine 505 (Sieh et al., 1993), respectively.
uch intramolecular binding inhibits the kinase. It is
ikely that both the SH3 and SH2 domains also interact
ith other proteins that function as regulators or effec-
ors of Lck. Lck is activated by phosphorylation of ty-
osine 394 (Hardwick and Sefton, 1995), which is found in
he activation loop of the catalytic domain, and inhibited by
hosphorylation of tyrosine 505 (Amrein and Sefton, 1988;
arth et al., 1988), which is found in a small, noncatalytic
omain at the carboxyl-terminus of the protein.
FIG. 1. Lck and Tip constructs used in this study. Indicated for Lck are
he N-terminal membrane-binding region containing two sites of fatty
cylation, the SH3 domain, the SH2 domain, the catalytic domain, and
he carboxyl-terminal regulatory domain. Indicated in the diagram of
ip are the presumptive transmembrane domain, residues 186–210;
BD1, residues 133–144; and LBD2, residues 100–113.Tip appears to be anchored to cellular membranes by
C-terminal transmembrane domain (Fig. 1) (Lund et al.,995). It contains two domains that are known to be
mportant for binding Lck (Jung et al., 1995a,b; Lund et al.,
996), one of which is a proline-rich region (residues
32–141) that has been termed the SH3B domain. Here
e refer to this domain as Lck-binding domain 1 (LBD1)
o avoid confusion with the SH3 domain of Lck (Fig. 1).
he other domain required for optimal binding is com-
rised of residues 104–113 and has some sequence
dentity to residues 488–497 in the aI helix at the car-
boxyl-terminal end of the Lck catalytic domain (Biesinger
et al., 1995). This domain in Tip has been referred to as
the CSKH domain (Fig. 1). Here we refer to this domain
as Lck-binding domain 2 (LBD2) (Fig. 1) to avoid confu-
sion with the Csk tyrosine kinase that is a negative
regulator of Lck activity (Bergman et al., 1992). Tip con-
tains no other identifiable protein–protein interaction do-
mains or domains with obvious catalytic function.
In the present study, we have sought to identify the
mechanism by which the HVS protein Tip from strain
484C associates with and modifies the activity of Lck. We
demonstrate that the binding between Lck and Tip in-
volves two domains of both proteins. We show that each
binding domain of Tip is involved in increasing the ac-
tivity of Lck. Our results further demonstrate that, in the
absence of other viral proteins, Tip is sufficient to induce
significant transcriptional activation in T cells.
RESULTS
There are two Tip-binding regions in Lck
The HVS Tip protein is known to bind to the Lck SH3
domain (Jung et al., 1995b). We wished to know whether
the SH3 domain was the sole site in Lck to which Tip
bound. Because Tip is difficult to express stably at easily
detectable levels, we addressed this question by tran-
sient coexpression of Tip and Lck in human 293 cells. We
observed avid and extensive binding of WT Tip to WT Lck
in this system (Figs. 2A and 2B). In this typical experi-
ment, 30% of the Lck and 100% of the Tip were found in
a Tip:Lck complex. Coexpression of Lck with Tip led to
the appearance of two additional forms of the Tip protein
that had greater apparent molecular weights than did the
species of Tip seen in cells expressing only Tip. These
novel species are both tyrosine phosphorylated (our un-
published data), and the additional phosphorylation may
explain their reduced gel mobility. The extensive phos-
phorylation of Tip raised the possibility that Lck could
bind to sites of tyrosine phosphorylation in Tip through
its SH2 domain. Such an interaction, however, is clearly
not essential for binding (see below).
To ask whether the SH3 domain of Lck was required
for complex formation, we coexpressed Tip with a form of
Lck lacking the entire SH3 domain, DSH3Lck (Fig. 1)
(Reynolds et al., 1992). To detect a complex between Tip
and DSH3Lck, we assayed for the presence of Lck by
incubation of immunoprecipitates in vitro with radioac-
p
2
t
f
2
t
c
T
m
p
c
o
t
a
t
t
c
1
2, anti-Lck immunoprecipitate from cotransfected cells; lane 3, anti-Lck
immunoprecipitate from cells transfected only with Tip. (C) Human 293
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341Tip ACTIVATION OF Lcktive ATP in a protein kinase reaction buffer. The DSH3Lck
rotein phosphorylated both itself and Tip in vitro (Fig.
C). DSH3Lck was readily detected in immunoprecipi-
ates prepared with anti-Tip antisera from cells cotrans-
ected with DSH3Lck and Tip expression vectors (Fig.
C). Similarly, Tip was apparent in the immunoprecipi-
ates prepared with anti-Lck antisera from the same
ells. Only the two tyrosine phosphorylated species of
ip were labeled during the in vitro reaction. The fastest
igrating species seen in Fig. 2B is not tyrosine phos-
horylated in vivo or in vitro. Quantitative analysis of the
extent of complex formation in this experiment using
immunoblotting with anti-phosphotyrosine antibodies
(data not shown) revealed that 100% of tyrosine-phos-
phorylated Tip was bound to WT Lck, whereas 44% of
tyrosine-phosphorylated Tip was bound to DSH3Lck.
Conversely, 40% of WT Lck was bound to Tip, whereas
13% or DSH3Lck was bound to Tip. This experiment
established that the SH3 domain of Lck was not essen-
tial for complex formation between the two proteins and
that extensive binding of Lck to Tip occurred in its ab-
cells were transfected with plasmids encoding either WT Lck, both WT
Lck and Tip, DSH3Lck, or both DSH3Lck and Tip. Immunoprecipitation
as carried out with either anti-Lck or anti-Tip antibodies, and the
mmunoprecipitates were incubated with [g-32P]ATP in vitro. Samples
ere subjected to SDS–PAGE, and labeled proteins were detected
sing a PhosphorImager. WT Lck, DSH3Lck, and Tip are indicated with
rrows; L, anti-Lck antiserum; T, anti-Tip antiserum. Lane 1, anti-Lck
mmunoprecipitate from cells transfected with WT Lck; lane 2, anti-Lck
mmunoprecipitate from cells transfected with WT Lck and Tip; lane 3,
nti-Tip immunoprecipitate from cells transfected with both WT Lck and
ip; lane 4, anti-Lck immunoprecipitate from cells transfected with
SH3Lck; lane 5, anti-Lck immunoprecipitate from cells transfected
ith DSH3Lck and Tip; lane 6, anti-Tip immunoprecipitate from cells
ransfected with DSH3Lck and Tip. (D) Human 293 cells were trans-
ected with plasmids encoding Myc-tagged Lck 186–509, both Myc-
agged Lck 186–509 and WT Tip, both Myc-tagged Lck 186–509 and
FL/AAA Tip, both Myc-tagged Lck 186–509, or WT Tip alone. Immu-
oprecipitation was carried out with rabbit anti-Tip antiserum, mouse
onoclonal anti-Myc antibodies, or a preimmune rabbit serum. Immu-
oprecipitates from 4 3 104 cells were loaded in each lane. Immuno-
precipitated Tip was detected by immunoblotting with anti-Tip antibod-
ies using 125I-protein A as a detection reagent and a PhosphorImager
or detection and quantification. The three Tip bands are indicated with
bracket. The DNAs used for transfection are indicated at the top. N
enotes samples prepared with a nonspecific antibody. L denotes
amples where Lck was immunoprecipitated with anti-Myc tag anti-
odies. T denotes samples prepared with anti-Tip antibodies. Lane 1,
ck 186–509 only, nonspecific antibody; lane 2, Lck 186–509 only,
nti-Myc antibody; lane 3, Lck 186–509 only, anti-Tip antiserum; lane 4,
ck 186–509 and WT Tip, nonspecific antibody; lane 5, Lck 186–509 and
T Tip, anti-Myc antibody; lane 6, Lck 186–509 and WT Tip, anti-Tip
ntiserum; lane 7, Lck 186–509 and SFL/AAA Tip, nonspecific antibody;
ane 8, Lck 186–509 and SFL/AAA Tip, anti-Myc antibody; lane 9, Lck
86–509 and SFL/AAA Tip, anti-Tip antiserum; lane 10, Lck 186–509 and
P/4A Tip, nonspecific antibody; lane 11, Lck 186–509 and 4P/4A Tip,
nti-Myc antibody; lane 12, Lck 186–509 and 4P/4A Tip, anti-Tip anti-FIG. 2. Tip and Lck bind to each other when coexpressed in 293
ells, and deletion of either the SH3 domain or the amino-terminal third
f Lck does not abolish binding. (A and B) Human 293 cells were
ransiently transfected with plasmids encoding Lck, Tip, or both Lck
nd Tip. Detergent-soluble lysates were prepared and immunoprecipi-
ation was carried out with antisera to either Lck or Tip under condi-
ions of antibody excess. The immunoprecipitates, and a portion of the
ell lysates equal to that used for immunoprecipitation (derived from
.6 3 104 cells), were subjected to SDS–PAGE. Lck and Tip were
quantified by immunoblotting with anti-Lck or anti-Tip antibodies using
125I-protein A as a secondary detection reagent. Immunoprecipitated
proteins were quantified using a PhosphorImager. (A) Anti-Lck immu-
noblot. Lane 1, lysate of cells cotransfected with Lck and Tip; lane 2,
anti-Tip immunoprecipitate from cotransfected cells; lane 3, anti-Tip
immunoprecipitate from cells transfected only with Lck. (B) Anti-Tip
immunoblot. Lane 1, lysate of cells cotransfected with Lck and Tip; laneody; lane 13, WT Tip only, nonspecific antibody; lane 14, WT Tip only,
nti-Myc antibody; lane 15, WT Tip only, anti-Tip antiserum.
342 HARTLEY ET AL.sence. This suggested the existence of a second Tip
binding site in Lck.
To further localize the second binding site in Lck, we
tested the ability of Tip to bind to a fragment of Lck,
consisting of residues 186–509, that had been tagged at
its amino terminus with six Myc tags (Fig. 1). This deleted
form lacks the unique amino-terminal membrane-binding
domain, the SH3 domain, and the majority of the SH2
domain. Clear binding of Tip to this fragment of Lck was
observed (Fig. 2D). The binding of the Myc-tagged 186–
509 fragment of Lck to Tip is notable, in that this form of
Lck lacks a membrane-binding domain. Additionally, the
binding of this fragment shows that a functional SH2
domain is not required for complex formation. The bind-
ing of Tip to this fragment established that there was a
Tip-binding site in the carboxyl-terminal half of Lck.
To define the sequences in Tip involved in binding to
the carboxyl-terminus of Lck, we examined the ability of
mutants of Tip lacking LBD1 or LBD2 to bind to this
fragment of Lck. To inactivate LBD1 and create a mutant
containing only functional LBD2, we converted prolines
135, 138, 139, and 141 to alanine (4P/4A Tip, Fig. 1). This
mutation abolished binding to Tip to a GST fusion protein
containing the Lck SH3 domain (data not shown). This
mutant Tip protein bound to the carboxyl-terminal frag-
ment of Lck as well as did wild-type Tip (Fig. 2D). LBD1
of Tip, therefore, apparently has no role in binding to Lck
in the absence of the Lck SH3 domain. Residues 108–110
in Tip are present in LBD2 and have been shown previ-
ously to be required for efficient binding to Lck (Jung et
al., 1995a). Mutation of these residues to alanine (SFL/
AAA Tip, Fig. 1) abolished detectable binding of Tip to
the 186–509 fragment of Lck (Fig. 2D). The ability of
wild-type Tip to bind to carboxyl-terminal half of Lck thus
appeared to be due to LBD2.
Properties of the Tip protein containing only one
functional Lck-binding domain
To study the interaction of Tip with Lck in more detail,
we measured the ability of Tip containing only one func-
tional Lck-binding domain to bind to WT Lck. Complexes
of Lck and Tip were isolated by immunoprecipitation in a
buffer containing 1% NP-40 detergent from transiently
transfected 293 cells. We always observe some nonspe-
cific precipitation of both Lck and Tip in this mild lysis
buffer. To quantify the nonspecific precipitation accu-
rately, control precipitates were prepared with antibodies
to either Lck or Tip from lysates of cells expressing only
Tip or Lck, respectively (Figs. 3A and 3B), or with non-
specific serum from doubly transfected cells (data not
shown). The nonspecific precipitation observed under
these conditions was quantified and subtracted from the
specific precipitation to yield accurate estimates of the
extent of complex formation. Mutant Tip containing either
only the proline-rich LBD1 or only LBD2 bound to WTLck, albeit to a reduced extent (Figs. 3A and 3B). In this
experiment, 56% of WT Tip was bound to Lck, whereas
27% of the Tip lacking LBD1 and 20% of the Tip lacking
LBD2 was found in a complex with Lck. No detectable
binding to Lck was observed with a mutant of Tip lacking
both LBD1 and LBD2 (data not shown).
We also tested the ability of the mutant Tips lacking
either a functional LBD1 or LBD2 to stimulate tyrosine
phosphorylation of cellular proteins (Fig. 3D). Expression
of Tip alone had no effect on tyrosine phosphorylation in
the cell lysate. The expression of Lck led to a small, but
detectable, increase in protein tyrosine phosphorylation,
much of which was due to the tyrosine phosphorylation
of Lck itself. Coexpression of WT or either mutant Tip
with Lck stimulated tyrosine phosphorylation of cellular
proteins considerably (Fig. 3D). The extent of protein
phosphorylation induced by the mutant Tip proteins,
however, was reduced relative to that induced by the WT
Tip protein (Fig. 3D). A mutant Tip protein carrying mu-
tations in both LBD1 and LBD2 exhibited little ability
to elevate tyrosine phosphorylation of cellular proteins
(Fig. 3D).
Activity of Tip mutants in T cells
We next tested the ability of the mutant Tip proteins to
stimulate transcription in transiently transfected Jurkat T
cells. Because Tip has been shown to stimulate Stat1
and Stat3 DNA binding (Lund et al., 1997, 1999), we first
examined the ability of the mutant Tip proteins to induce
increased transcription from a reporter that has been
shown previously to respond to the activation of Stat3
(Turkson et al., 1998). Because Tip was not detectable in
these transfected cells, differences in transfection effi-
ciency were corrected for by the inclusion in each trans-
fection of a plasmid expressing Renilla luciferase from
an actin promoter. The data shown here are from a single
experiment and are representative of the results of seven
experiments with Stat-responsive reporters. WT Tip in-
duced a fivefold increase in expression of luciferase
driven by this reporter (Fig. 4). This was considerably
greater than the 40% stimulation induced by activated
Lck (F505Lck). Both LBD1- and LBD2-mutant Tip proteins
stimulated expression from this reporter. The mutant
containing only LBD2 (4P/4A Tip) consistently showed
more activity (75% of that of wild-type Tip) than the
mutant containing only LBD1 (SFL/AAA Tip). Doubly mu-
tant Tip containing both a mutant LBD1 and a mutant
LBD2 exhibited no activity in this assay (Fig. 4).
In contrast to the Stat3-responsive reporter, both WT
Tip and activated Lck stimulated transcription from a
cotransfected reporter construct driven by a promoter
containing NF-AT (Nuclear factor of activated T-cells)
sites, inducing a six- to 10-fold increase in transcription
(Fig. 4). Strikingly, neither the LBD1 nor the LBD2 mutant
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Tip, or both Lck and AAA14A (doubly mutant). Tip and detergent-
soluble lysates were prepared. Immunoprecipitates were prepared
343Tip ACTIVATION OF LckTip was able to induce significant NF-AT-dependent tran-
scription in any of 10 experiments.
DISCUSSION
It was established previously that two regions of Tip
were involved in the binding of the protein to Lck (Jung et
al., 1995a; Lund et al., 1996). We have shown here that
these two domains bind to different sites in Lck. The
proline-rich LBD1 binds to the SH3 domain in Lck (Fig. 5).
LBD2, a region with the sequence EDLQSFLEKY, binds
an as-yet-unidentified site in the carboxyl-terminal half of
Lck (Fig. 5). Precise mapping of where in the carboxyl-
terminal portion of Lck the Tip LBD2 binds will probably
come only from determination of the crystal structure of
the complex. The binding of Tip through either domain
activates Lck detectably in vivo. Activation was apparent
rom analysis of the phosphorylation of cellular proteins
n transfected 293 cells expressing both Lck and Tip, and
y transient cotransfection of Jurkat T cells with Tip and
reporter construct driven by a Stat-responsive pro-
oter. The biological activity of mutants of Tip lacking
ither Lck-binding domain, however, was clearly not
quivalent to that of the WT protein. This was most
pparent from the fact that neither mutant Tip protein
xhibited sufficient activity in T cells to stimulate tran-
cription from a reporter containing three NF-AT sites.
dditionally, both mutant Tip proteins differ from WT Tip
with anti-Lck or anti-Tip antiserum in antibody excess. The immuno-
precipitates and a portion of the cell lysate equal to that used for
immunoprecipitation (from 1.6 3 104 cells) were subjected to SDS–
PAGE. Lck and Tip were quantified by immunoblotting with anti-Lck (A)
or anti-Tip (B) antibodies respectively, using 125I-protein A as a detection
reagent. Lck and Tip are indicated with arrows. (A) Anti-Lck immuno-
blot. Lane 1, untransfected cell lysate; lane 2, Lck and WT Tip lysate;
lane 3, Lck and 4P/4A Tip lysate; lane 4, Lck and SFL/AAA Tip lysate;
lane 5, anti-Tip immunoprecipitate from Lck and WT Tip lysate; lane 6,
anti-Tip immunoprecipitate from Lck and 4P/4A Tip lysate; lane 7,
anti-Tip immunoprecipitate from Lck and SFL/AAA Tip lysate; lane 8,
anti-Tip immunoprecipitate from lysate of cells transfected with only
Lck DNA. (B) Anti-Tip immunoblot of the samples from the same
experiment as in (A). Lane 1, untransfected cell lysate; lane 2, Lck and
WT Tip lysate; lane 3, Lck and 4P/4A Tip lysate; lane 4, Lck and
SFL/AAA Tip lysate; lane 5, anti-Lck immunoprecipitate from Lck and
WT Tip lysate; lane 6, anti-Lck immunoprecipitate from Lck and 4P/4A
Tip lysate; lane 7, anti-Lck immunoprecipitate from Lck and SFL/AAA
Tip lysate; lane 8, anti-Lck immunoprecipitate from lysate of cells
transfected with only Tip DNA. (C, D, and E) Data from a separate
experiment analyzing tyrosine phosphorylation induced by the mutant
Tip proteins. Tip levels, Lck levels, and tyrosine phosphorylation in cell
lysates (from 4 3 104 cells) were quantified by Western blotting anal-
ysis with antibodies to Tip, Lck, or phosphotyrosine using 125I-protein A
as a detection reagent. Detection was accomplished with a Phosphor-
Imager. The same samples were analyzed in (C), (D), and (E). (C)
Anti-Tip immunoblot of cell lysates. (D) Anti-phosphotyrosine immuno-
blot of cell lysates. (E) Anti-Lck immunoblot of cell lysates. Lane 1,
untransfected cells; lane 2, WT Tip alone; lane 3, Lck alone; lane 4, LckFIG. 3. Both SFL/AAA Tip and 4P/4A Tip bind to and activate Lck.
Human 293 cells were transfected with plasmids encoding Lck, WT Tip,
both Lck and WT Tip, both Lck and SFL/AAA Tip, both Lck and 4P/4Aand WT Tip; lane 5, Lck and 4P/4A (LBD2 only) Tip; lane 6, Lck and
SFL/AAA (LBD1 only) Tip; lane 7, Lck and AAA14A Tip.
i
p
L
m
t
c
g
a
t
i
b
n
t
i
t
m
q
t
r
344 HARTLEY ET AL.in that they cannot activate Lck detectably in a cell-free
system (Hartley et al., 1999). We do not yet know whether
ntact cells contain a factor that helps stabilize the com-
lex of mutant Tip and Lck, or whether modification of
FIG. 4. The ability of Tip mutants to stimulate transcription from Stat3-
and NF-AT-responsive reporters in Jurkat cells. Jurkat T antigen cells were
transfected with plasmids encoding a Stat3-responsive firefly luciferase
reporter (top panel) or an NF-AT-responsive firefly luciferase reporter (bot-
tom panel) together with plasmids encoding WT Tip, SFL/AAA Tip, 4P/4A
Tip, doubly mutant AAA14A Tip, or activated F505 Lck. Cells transfected
with only the reporter construct were incubated with 60 nmol phorbol
myristyl acetate (PMA) and 1.5 mmol ionomycin (Calbiochem) for 4 h to
imic stimulation of the T-cell antigen receptor. Luciferase levels were
uantified as described under Materials and Methods. (—) indicates cells
ransfected only with the reporter. P1I indicates cells transfected with the
eporter and incubated with PMA and ionomycin.ck must occur in intact cells to allow activation by the
utant Tip proteins.The ability of each binding domain to partially activate
Lck suggests that activation of Lck by WT Tip has two
components that must cooperate to fully activate Lck.
The binding of LBD1 to the SH3 domain of Lck probably
activates Lck by displacement of the SH3 domain of Lck
(Fig. 5). The structure of two Src kinases, Hck and c-Src,
has been determined (Sicheri et al., 1997; Williams et al.,
1997; Xu et al., 1997). In both structures the SH3 domains
of the kinases were found to be bound intramolecularly
to a polyproline II helix formed by the linker between the
SH2 domain and the catalytic domain. It is thought that
this interaction constrains the catalytic domain and
thereby inhibits the assumption of a catalytically active
conformation. The Nef protein of human immunodefi-
ciency virus is a high-affinity ligand for the SH3 domain
of Hck (Lee et al., 1995; Saksela et al., 1995). The addition
of Nef to Hck stimulates the kinase activity of Hck
(Moarefi et al., 1997). It is likely that this activation results
from the binding of Nef to the SH3 domain, displacement
of the SH3 domain from the SH2/catalytic domain linker,
and removal of conformational constraints. Although the
crystal structure of Lck has not yet been determined, it is
reasonable to assume that the SH3 domain of Lck can
bind intramolecularly to the region surrounding Pro 229
in the SH2/catalytic domain linker (Fig. 5). Such an inter-
action would be expected to be inhibitory, an idea that is
supported by the fact that mutations in this region acti-
vate Lck (Gonfloni et al., 1997; Wright et al., 1994). It is
likely, therefore, that the binding of the proline-rich LBD1
of Tip to the Lck SH3 domain relaxes the constrained
conformation and increases the catalytic activity of Lck
(Fig. 5).
How the binding of LBD2 in Tip to the carboxyl-termi-
nal half of Lck stimulates catalytic activity is less obvious.
Two possible mechanisms can be considered. The LBD2
domain of Tip has some sequence identity to the aI helix
hat is found at the carboxyl-terminal end of the Lck
atalytic domain. Additionally, the PredictProtein pro-
ram (Rost, 1996) predicts that this domain in Tip will
ssume an a-helical conformation. It is possible that,
hrough a mechanism similar to that envisioned for the
nteraction of LBD1 with the SH3 domain, the LBD2 of Tip
inds to the catalytic domain where the aI helix does so
ormally, displaces the aI helix, and that this perturba-
ion is activating. Consistent with the possibility that an
nteraction with the aI helix could be activating is the
finding that two spontaneous mutations of the c-Src gene
that activate the enzyme are found in positions Glu378
and Ile441 (Levy et al., 1986), both of which impinge on
he aI helix (Sicheri et al., 1997).
Alternatively, it is conceivable that LBD2 of Tip acti-
vates Lck through a mechanism similar to the activation
of the cyclin-dependent protein kinases by cyclins. Cyc-
lins bind to CDKs in the small, amino-terminal lobe of the
catalytic domain (Jeffrey et al., 1995). This binding in-
duces, or allows, the reorientation of the aC helix. It is
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345Tip ACTIVATION OF Lckformally possible that LBD2 also binds to the small,
amino-terminal lobe of the catalytic domain and this
binding induces reorientation of the aC helix. Clarifica-
tion of the actual mechanism of activation of Lck by Tip,
however, will come only from structural analysis.
Both Tip and Lck are membrane proteins; however,
this property does not play an essential role in their
interaction. We found that a form of Lck in which the
membrane-binding domain had been deleted and re-
placed with six Myc tags still bound to Tip (Fig. 2D).
Additionally, Tip lacking its carboxyl-terminal membrane
anchor activates Lck in T cells (Lund et al., 1999). These
data suggest that the affinity of Tip for Lck is sufficiently
great that colocalization of the two proteins on cellular
membranes is not required for complex formation. Be-
cause a majority of Tip undergoes tyrosine phosphory-
lation when coexpressed with Lck (our unpublished ob-
servations), it was possible that the SH2 domain of Lck
played a role in complex formation. The fact that the
186–509 fragment of Lck, which lacks the majority of the
SH2 domain, binds to Tip (Fig. 2D) demonstrates that the
SH2 domain of Lck is certainly not required for binding.
It is possible, however, that the SH2 domain stabilizes
the complex.
Although the ability of the Tip protein of HVS, strain
488C, to bind to Lck in vitro is reduced by mutation of
prolines in LBD1 (Duboise et al., 1998b; Jung et al.,
1995a), a virus carrying this mutation is reported to still
FIG. 5. Structure of Lck and hypothetical model of how Tip binds to
the absence of Tip, is bound to the linker between the SH2 domain an
tyrosine 505. Tyrosine 394 in the activation loop is not phosphorylated
the SH3 domain, presumably displacing it and disrupting the intramolec
site in the carboxyl-terminal half of Lck. LBD2 is shown here binding t
to an increased extent at tyrosine 394 (Hartley et al., 1999). The increabe able to induce lymphomas in vivo (Duboise et al.,
998b). This observation is consistent with our finding
a
chat mutation of prolines in LBD1 of the Tip from strain
84C reduces, but does not eliminate, the ability of the
rotein to stimulate protein phosphorylation and tran-
cription from a Stat-responsive promoter. It has been
eported that the mutation of LBD1 of strain 488C abol-
shes detectable binding of Tip to Lck in leukemic cells in
ivo (Duboise et al., 1998b), and this has been interpreted
o mean that the binding of Tip to Lck is not required for
isease induction. In contrast, we found that complexes
etween Lck and Tip with a mutated LBD1 can be de-
ected, albeit at a lower level than those seen with the
T protein, in transiently transfected 293 cells. Because
ip is expressed at extremely low levels in virally in-
ected leukemic cells, a complex between Tip and Lck
ith reduced stability might well be extremely difficult to
etect.
We note that, whereas we find the Tip protein from
train 484C of Herpesvirus saimiri to activate Lck, the
losely related Tip protein from strain 488C of Herpesvi-
us saimiri is reported to inhibit Lck (Jung et al., 1995b).
dditionally, mutation of Tyr114 in Tip from strain 488C
ncreases both the binding of Tip to Lck and the inhibi-
ion of Lck (Guo et al., 1997). The question of why these
wo closely related viral transforming proteins have ap-
arently completely opposite effects on Lck remains un-
nswered.
The Tip protein of HVS is similar to two other viral
roteins that target Src kinases, the Nef protein of HIV
e structures of c-Src and Hck suggest that the SH3 domain of Lck, in
atalytic domain and that the SH2 domain is bound to phosphorylated
form of Lck. Tip binds to two sites in Lck. Proline-rich LBD1 binds to
mplex. The LBD2 region of Tip binds to an as-yet imprecisely mapped
rge lobe of the catalytic domain. Lck bound to Tip is phosphorylated
osphorylation of this site almost certainly contributes to activation.Lck. Th
d the c
in this
ular cond the middle T antigen of polyoma virus. Like Nef, Tip
ontains a domain that binds to an SH3 domain; how-
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346 HARTLEY ET AL.ever, Tip is not simply an SH3 domain ligand. Like middle
T antigen (Dunant et al., 1996), Tip contains a domain
hat interacts with the carboxyl-terminal half of Src ki-
ases. Thus, Tip is unique in that it contains two Src
inase binding domains, both of which are required for
ull activity. Viral transforming proteins often function as
imics of cellular proteins, which may also be the case
or Tip. There may well exist in T cells a cellular protein
hat is analogous to Tip in functioning as an activator of
ck through binding interactions with both the SH3 do-
ain and the catalytic domain. Such a protein could play
n important role in T-cell responses. There are sugges-
ions that the b-arrestin protein may activate the c-Src
inase through binding interactions (Luttrell et al., 1999;
Miller et al., 2000) that have some similarity to those by
which Tip activates Lck. It is clearly of considerable
interest to determine whether there is a normal cellular
protein that is a functional homolog of Tip.
MATERIALS AND METHODS
Antibodies and cell lines
Polyclonal antiserum to the Herpesvirus saimiri Tip
protein was raised in rabbits using a GST fusion protein
containing amino acids 1–84 of Tip-484C. Specificity of
this antisera was confirmed by comparison to a previ-
ously characterized anti-Tip sera (Lund et al., 1997). The
rabbit anti-Lck (Hurley and Sefton, 1989) and rabbit anti-
phosphotyrosine (Kamps and Sefton, 1988) antibodies
have been described previously. The 9E10 monoclonal
anti-Myc antibody (Evan et al., 1985) was kindly provided
by Jill Meisenhelder and Tony Hunter (The Salk Institute).
Human 293 cells were grown in DMEM supplemented
with either 5% fetal calf serum (Intergen, Purchase, NY)
and 5% iron-supplemented calf serum (Gemini Bio-Prod-
ucts, Calabasas, CA) or 10% iron-supplemented calf se-
rum and penicillin/streptomycin. Jurkat cells that express
the large T antigen of SV40 virus (Northrop et al., 1993)
were kindly provided by Jack Bui and maintained in RPMI
1640 medium supplemented with 10% fetal calf serum, 2
mM glutamine, and penicillin/streptomycin.
Plasmid expression vectors
The Tip and Lck constructs are diagrammed in Fig. 1.
To inactivate LBD1, PCR mutagenesis was used to
change prolines 135, 138, 139, and 141 to alanine (4P/4A
Tip, Fig. 1). To inactivate LBD2, we mutated three resi-
dues, Ser108, Phe109, and Leu110, to alanines (SFL/AAA
Tip, Fig. 1). All mutations were confirmed by sequencing.
For transfection of 293 cells, all Tip constructs were
inserted into the pCEP4 vector (Invitrogen, Carlsbad, CA).
For T-antigen Jurkat cell transfection, Tip constructs were
moved to the pRc/RSV vector (Invitrogen).The DSH3Lck construct, derived from murine Lck and
previously described (Reynolds et al., 1992), was ex- dpressed using the pCMX vector (Umesono et al., 1991).
Lck 186–509 was generated by subcloning of an XhoI–
EcoRI fragment from DSH2F505Lck in the plasmid LXSN
(Reynolds et al., 1992) into CS31MT (a gift of Dr. Jon
Cooper, Fred Hutchinson Cancer Research Center). This
vector appends six Myc tags to the amino terminus.
Wild-type (WT) Lck was expressed in 293 cells using the
pCEP4 vector. F505 Lck, a constitutively activated form of
Lck (Amrein and Sefton, 1988), was expressed in T-
antigen Jurkat cells using either the SRa3 vector or the
pRcRSV vector. Two firefly luciferase reporter constructs,
one containing a promoter consisting of three copies of
an NF-AT site and a fragment of the human interleukin-2
promoter (Northrop et al., 1993) (a gift from J. Bui), the
other containing seven copies of a Stat3-responsive el-
ement from the C-reactive protein gene (Turkson et al.,
1998) (a gift from Richard Jove, Moffitt Cancer Center),
were used. A plasmid encoding Renilla luciferase under
the control of the b-actin promoter was a gift of Christo-
pher Herold (UCSD).
Protein expression, immunoprecipitation, and
immunoblotting
Human 293 cells were seeded at 4.5 3 105 cells per
0-mm gelatin-coated petri dishes the day prior to trans-
ection, which was performed using a standard calcium-
hosphate precipitation technique. At 48 h posttransfec-
ion the cells were lysed in 600 mL of 1% Nonidet-P40, 20
mM Tris (pH 7.8), 150 mM sodium chloride, 1 mM sodium
vanadate, 2 mM EDTA, and 10 KIU/ml Aprotinin. Lysates
were then clarified by centrifugation at 10,000 g for 15
min at 4°C. Cleared lysates were incubated for 40–60
min at 4°C with 1 mL of the specified primary antisera.
ansorbin cells (Calbiochem, La Jolla, CA) were added,
nd incubations continued for a further 20–60 min. Im-
une complexes were then washed three to five times.
mmunoprecipitates and cell lysates were subjected to
DS–PAGE and transferred to Protran (Schleicher and
chuell, Keene, NH) or Immobilon-P (Millipore, Bedford,
A) for immunoblotting. Primary antibodies were de-
ected with 10 mCi 125I-protein A (ICN, Irvine, CA).
Assays of kinase activity
After washing, precipitates were resuspended in 10
mL of kinase assay buffer (40 mM PIPES, pH 7.0, and 10
mM MnCl2). An additional 10 mL of kinase buffer was
added containing 5 mCi [g-32P]ATP (3000 Ci/mmol; Am-
ersham, Arlington Heights, IL), and samples were incu-
bated at 30°C for 10 min. The reaction was stopped by
the addition of 1 ml of a cold 50 mM Tris (pH 7.8), 150 mM
NaCl, and 0.01% NP-40 solution; samples were pelleted;
32and the supernatant containing unincorporated P was
iscarded.
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T-antigen Jurkat cells were transfected with 1 mg of
uciferase reporter and 3 mg of an expression vector
ontaining Tip DNA, Lck DNA, or no insert. Transfection
as performed with DMRIE-C using the protocol recom-
ended by the supplier (Life Technologies, Gaithers-
urg, MD). A 200-ng sample of a reporter construct
xpressing Renilla luciferase under control of the b-actin
romoter was included in each transfection. After 48 h
pproximately 4 3 106 transfected cells were washed
nce in cold PBS (without Ca21 or Mg21) followed by
resuspension in 100 mL lysis buffer (0.1 M potassium
phosphate, pH 7.8, 1% Triton X-100, 1 mM DTT, and 2 mM
EDTA). Cells were incubated for 20 min at 4°C before
pelleting to remove insoluble material. Supernatants
were removed and placed on ice until analyzed. Aliquots
(30 mL) from each sample were mixed with 100 mL assay
buffer (30 mM Tricine, 3 mM ATP, 15 mM MgSO4, and 10
M DTT, final pH 7.8) immediately prior to reading in a
erthold Lumat LB 9507 luminometer. The reactions
ere initiated by injection of 100 mL of freshly prepared
1 mM D-luciferin (pH 6.1–6.5) into each sample. The
luciferase assay was quenched with Stop & Glo (Pro-
mega, Madison, WI) and the activity of the Renilla en-
yme was measured. This value was used as a measure
f transfection efficiency and was used to normalize the
irefly luciferase data.
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